Deactivation of regulatory proteins hnRNP A1 and A2 during SC-1 induced apoptosis

Human Antibodies

Volumn 10, Issue 2, 2001, Pages 83-90

  Hermann, Ralph ^a   Hensel, Frank ^a   Müller, Eva Christina ^b   Keppler, Marc ^a   Souto Carneiro, Margarida ^a   Brändlein, Stephanie ^a   Müller Hermelink, Hans Konrad ^a   Peter Vollmers, H ^a  

^a Institute of Pathology   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Apoptosis; HnRNP; SC 1; Stomach carcinoma

Indexed keywords

CASPASE; MONOCLONAL ANTIBODY; OKADAIC ACID; PROTEIN SERINE KINASE; RIBONUCLEOPROTEIN;

APOPTOSIS; ARTICLE; CELL DEATH; CELL LYSATE; CELL PROLIFERATION; COMPLEMENT ACTIVATION; CROSS REACTION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA;

EID: 0034774984     PISSN: 10932607     EISSN: None     Source Type: Journal    
DOI: 10.3233/hab-2001-10205     Document Type: Article

References (44)

1. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
2. Cell cycle-regulated phosphorylation of the pre-mRNA-binding (heterogeneous nuclear ribonucleoprotein) C proteins
3. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly reduces apoptosis
4. Identification and characterization of a new member of the TNF family that reduces apoptosis
5. Purification and characterization of the Fas-ligand that induces apoptosis
6. The Fas death factor
7. Lethal effect of the anti-Fas antibody in mice
8. Tumor-specific apoptosis by the human monoclonal antibody SC-1: A new therapeutical approach for stomach cancer
9. Adjuvant therapy for gastric adenocarcinoma with the apoptosis-inducing human monoclonal antibody SC-1: First clinical and histopathological results
10. SC-1, a functional human monoclonal antibody against autologous stomach carcinoma cells
11. Apoptosis of stomach carcinoma cells induced by a human monoclonal antibody
12. Characterisation of glycosylphosphatidylinositol-linked molecule CD55/Decay-accelerating factor as the receptor for antibody SC-1-reduced apoptosis
13. Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins
14. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes
15. Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement
16. Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipid
17. Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland
18. Isolation of two forms of decay-accelerating factor (DAF) from human urine
19. Additional forms of human decay-accelerating factor (DAF)
20. Isolation of an active gene encoding human hnRNP protein A1. Evidence for alternative splicing
21. Primary structures of the heterogeneous nuclear ribonucleoprotein A2, B1, and C2 proteins: A diversity of RNA binding proteins is generated by small peptide inserts
22. Identification of apoptosis-associated proteins in a human Burkitt lymphoma cell line. Cleavage of heterogeneous nuclear ribonucleoprotein A1 by caspase 3
23. Caspases: Enemies within
24. Regulation of Ich-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors
25. Characterization of four new gastric cancer cell lines
26. Differential expression of apoptosis receptors on diffuse and intestinal type stomach carcinoma
27. Study of Burkitt lymphoma cell line proteins by high resolution two-dimensional gel electrophoresis and nanoelectrospray mass spectrometry
28. Identification of human myocardial proteins separated by two-dimensional electrophoresis using an effective sample preparation for mass spectrometry
29. Error-tolerant identification of peptides in sequence databases by peptide sequence tags
30. Serine/threonine phosphorylation regulates binding of C hnRNP proteins to pre-mRNA
31. Transcriptional regulation of the complement receptor 2 gene: Role of a heterogeneous nuclear ribonucleoprotein
32. hnRNP C increases amyloid precursor protein (APP) production by stabilizing APP mRNA
33. Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death
34. Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis
35. Characterization and primary structure of the poly(C)-binding heterogeneous nuclear ribonucleoprotein complex K protein
36. Identification, molecular cloning, expression and chromosome mapping of a family of transformation upregulated hnRNP-K proteins derived by alternative splicing
37. Cell type-specific expression of hnRNP proteins
38. Molecular characterization of the hnRNP A2/B1 proteins: Tissue-specific expression and novel isoforms
39. Identification of heterogeneous ribonucleoprotein A1 as a novel substrate for protein kinase C zeta
40. Regulation of in vitro nucleic acid strand annealing activity of heterogeneous nuclear ribonucleoprotein protein A1 by reversible phosphorylation
41. Heterogeneous nuclear ribonucleoprotein A2 interacts with protein kinase CK2
42. Regulated interaction of protein kinase Cdelta with the heterogeneous nuclear ribonucleoprotein K protein
43. Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element
44. Heteronuclear, ribonucleoproteins C1 and C2, components of the spliceosome, are specific targets of interleukin 1beta-converting enzyme-like proteases in apoptosis